RNVA Rennova Health Inc

USD 0.00 0.00 0
Icon

Rennova Health Inc (RNVA) Stock Analysis and Price Targets

COMMON STOCK | Diagnostics & Research | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.0001

0.00 (0.00)%

USD 0.04M

2.28M

N/A

N/A

Icon

RNVA

Rennova Health Inc (USD)
COMMON STOCK | OTC
USD 0.00
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.04M

N/A

USD 0.00

Rennova Health Inc (RNVA) Stock Forecast

N/A

Based on the Rennova Health Inc stock forecast from 0 analysts, the average analyst target price for Rennova Health Inc is not available over the next 12 months. Rennova Health Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Rennova Health Inc is Neutral, which is based on 5 positive signals and 5 negative signals. At the last closing, Rennova Health Inc’s stock price was USD 0.0001. Rennova Health Inc’s stock price has changed by +0.00% over the past week, +0.00% over the past month and +0.00% over the last year.

No recent analyst target price found for Rennova Health Inc
No recent average analyst rating found for Rennova Health Inc

Company Overview Rennova Health Inc

Rennova Health, Inc., together with its subsidiaries, provides health care services in the United States. It owns one operating hospital in Oneida, Tennessee; and a rural clinic in Williamsburg, Kentucky. The company is based in West Palm Beach, Florida.

400 South Australian Avenue, West Palm Beach, FL, United States, 33401

85

December

USD

USA

Adjusted Closing Price for Rennova Health Inc (RNVA)

Loading...

Unadjusted Closing Price for Rennova Health Inc (RNVA)

Loading...

Share Trading Volume for Rennova Health Inc Shares

Loading...

Compare Performance of Rennova Health Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for RNVA

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Rennova Health Inc (Sector: Diagnostics & Research )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
IDXX
IDEXX Laboratories Inc -5.02 (-1.02%) USD44.10B 52.65 36.72

ETFs Containing RNVA

Symbol Name RNVA's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Rennova Health Inc (RNVA) Stock

Stock Target Advisor's fundamental analysis for Rennova Health Inc's stock is Neutral.

Unfortunately we do not have enough data on RNVA's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on RNVA's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on RNVA's stock to indicate if its overvalued.

The last closing price of RNVA's stock was USD 0.00.

The most recent market capitalization for RNVA is USD 0.04M.

Unfortunately we do not have enough analyst data on RNVA's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Rennova Health Inc's stock.

As per our most recent records Rennova Health Inc has 85 Employees.

Rennova Health Inc's registered address is 400 South Australian Avenue, West Palm Beach, FL, United States, 33401. You can get more information about it from Rennova Health Inc's website at https://www.rennovahealth.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...